Expression Enhanced Natural Product Pathways Using Advanced Metagenomic Tools
Expression Enhanced Natural Product Pathways Using Advanced Metagenomic Tools
批准号:
9025682
负责人:
Scott Allen Monsma
金额:
$34.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-03-01 至 2017-07-31
关键词:
AddressAnabolismAnti-Bacterial AgentsAnti-Infective AgentsAntibioticsAntifungal AgentsBacterial Artificial ChromosomesBiological AssayBuffaloesCenters for Disease Control and Prevention (U.S.)ChemicalsChemistryClinicalCloningCollectionComplexDNADataEngineeringEnvironmentEscherichia coliGene ExpressionGenesGeneticGenomicsGoalsGrowthHealthHigh-Throughput Nucleotide SequencingLeadLibrariesMarketingMeasurableMetagenomicsMethodsMicrobeMulti-Drug ResistanceNatural Product DrugNatural ProductsOutcomeOutcomes ResearchPathway interactionsPatientsPersonal SatisfactionProceduresProcessProductionPropertyReportingSequence AnalysisSeriesSourceTechnologyTherapeuticTherapeutic AgentsTimeTranslationsViralantimicrobialbasecellular engineeringcostdesigndrug discoverydrug resistant bacteriaimprovedinnovative technologiesinterestlarge scale productionmicrobialnext generationnovelpathogenscreeningsmall moleculesmall molecule therapeuticssuccesstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): A post-antibiotic era of multiple drug resistance has begun to threaten the health and well-being of mankind. A crucial limitation in economically converting untapped natural product potential to final scalable production is the lack of next-generation tools to effectively access the full medicinal impact of natural environments. This project utilizes innovative technologies to capture entire small molecule pathways and express them for the first time in E. coli, resulting in a potent pipeline of novel environmentally-derived
therapeutic compounds. There are two unique components available to achieve this goal: 1) A new strain of engineered E. coli to support many of the unique building blocks needed for expression of natural product biosynthetic pathways and 2) A BAC library of 800 clones containing entire small molecule pathways up to 170 kb to be assayed for expression of anti-bacterial activities against the ESKAPE series of pathogens. The outcomes of this research are expected to significantly accelerate the discovery and production of novel antimicrobial compounds.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1002/btpr.2567
发表时间:
2018-01
期刊:
Biotechnology progress
影响因子:
2.9
作者:
[Fang L, Guell M, Church GM, Pfeifer BA]
通讯作者:
Pfeifer BA
A Novel Method to Improve Function of SC-Derived Hepatocytes
-
批准号:8314618
-
项目类别:
-
资助金额:$32.82万
-
财政年份:2012
-
负责人:Scott Allen Monsma
-
依托单位:
A Novel System for Mass Production of iPS Cells
-
批准号:8060436
-
项目类别:
-
资助金额:$34.39万
-
财政年份:2011
-
负责人:Scott Allen Monsma
-
依托单位:
New Multiplexed Quantitative Detection of Pluripotency and Germ Layer Proteins
-
批准号:7910384
-
项目类别:
-
资助金额:$78.13万
-
财政年份:2009
-
负责人:Scott Allen Monsma
-
依托单位:
Multiplexed Microarray Detection of Pluripotency Related Proteins
-
批准号:7610858
-
项目类别:
-
资助金额:$18.46万
-
财政年份:2009
-
负责人:Scott Allen Monsma
-
依托单位:
A Novel Multiplexed Assay for Rapid Antibody Screening
-
批准号:8314092
-
项目类别:
-
资助金额:$38.36万
-
财政年份:2008
-
负责人:Scott Allen Monsma
-
依托单位:
A Novel Multiplexed Assay for Rapid Antibody Screening
-
批准号:7999091
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2008
-
负责人:Scott Allen Monsma
-
依托单位:
Novel Assay for Rapid Antibody Screening
-
批准号:7676191
-
项目类别:
-
资助金额:$14.55万
-
财政年份:2008
-
负责人:Scott Allen Monsma
-
依托单位:
Novel Assay for Rapid Antibody Screening
-
批准号:7536704
-
项目类别:
-
资助金额:$21.72万
-
财政年份:2008
-
负责人:Scott Allen Monsma
-
依托单位:
A Novel Multiplexed Assay for Rapid Antibody Screening
-
批准号:8135401
-
项目类别:
-
资助金额:$39.03万
-
财政年份:2008
-
负责人:Scott Allen Monsma
-
依托单位:
海外基金